Skip to main content

Table 1 Baseline characteristics of 617 patients with cardiovascular disease according to level of cardiovascular multimorbidity

From: The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study

Characteristic CVD only
(n = 339)
CVD & CKD
(n = 203)
CVD & Anaemia
(n = 38)
CVD & CKD & Anaemia
(n = 37)
p value*
Mean eGFR (ml/min/1.73 m 2 ) (SD) 74.47 (13.4) 51.18 (10.3) 72.08 (11.6) 45.81 (14.5) <0.01
Mean Hb (g/dL) (SD) 14.50 (1.11) 13.95 (1.14) 11.13 (1.57) 11.05 (1.53) <0.01
Mean Age in years (SD) 64.49 (8.9) 69.74 (7.48) 66.90 (9.62) 72.64 (4.99) <0.01
Female sex (%) 27.4 60.3 39.5 63.1 <0.01
Current Smoker (%) 30.4 24.8 40.0 30.8 0.676
Previous CVD event (%)      
MI 46.6 41.1 44.7 55.3 0.361
Angina 83.7 88.7 86.8 81.6 0.379
Heart Failure 8.0 11.8 7.9 10.5 0.502
Previous Co-morbidity (%)      
Peripheral vascular disease 5.0 7.8 5.3 10.5 0.347
Stroke 4.4 5.9 2.6 0.0 0.481
Thromboembolism(PE, DVT, TIA) 10.3 18.1 2.6 10.5 0.012
Baseline Clinical status (SD)      
Systolic blood pressure (mm Hg) 137.2 (17.7) 138.8 (19.8) 133.8 (15.5) 139.6 (21.3) 0.418
Diastolic blood pressure (mm Hg) 80.6 (9.3) 79.9 (8.7) 77.2 (10.0) 81.2 (8.4) 0.172
Total Cholesterol (mmol/L) 5.3 (0.97) 5.4 (1.0) 4.9 (0.9) 5.5 (1.4) 0.031
Baseline medication (%)      
Aspirin 75.4 67.5 71.0 81.6 0.131
B-Blocker 51.0 46.3 55.3 34.2 0.170
Lipid-lowering agent 50.7 50.7 36.8 28.9 0.029
ACE Inhibitor 25.2 25.1 26.3 31.6 0.854
  1. *p value refers to the one-way ANOVA and Chi-squared analyses comparing the 4 groups